What is Solid Biosciences Inc.'s debt-to-assets?

Solid Biosciences Inc. (SLDB) reported debt-to-assets of 0× in Q1 2026.

How has Solid Biosciences Inc.'s debt-to-assets changed year-over-year?

Solid Biosciences Inc.'s debt-to-assets decreased by 28.8% year-over-year, from 0.1× to 0×.

What is the long-term trend for Solid Biosciences Inc.'s debt-to-assets?

Over 5 years (2020 to 2025), Solid Biosciences Inc.'s debt-to-assets has grown at a 23.8% compound annual growth rate (CAGR), from 0× to 0.1×.

What does debt-to-assets mean?

Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.

Solid Biosciences Inc. SLDB Debt-to-assets

Debt-to-assets at other companies

Sarepta Therapeutics, Inc.SRPT

0.1×0.0×

BiogenBIIB

0.2×0.0×

Neurocrine BiosciencesNBIX

0.1×0.0×

InsmedINSM

0.3×-0.4×

Dyne Therapeutics, Inc.DYN

0.2×+0.1×

Taysha Gene Therapies, Inc.TSHA

0.2×-0.2×

Other financials

Income statement

See full

Revenue$2.0M-40.6%

Operating income-$57.3M-43.1%

Net income-$56.7M-44.4%

EPS (diluted)-$0.52+11.9%

Balance sheet

See full

Cash & equivalents$297.1M+41.1%

Total debt$20.7M-12.5%

Total equity$374.1M+27.1%

Total assets$422.9M+23.0%

Cash flow

See full

Operating cash flow-$47.2M-48.3%

CapEx$165.0K+31.0%

Free cash flow-$47.4M-48.2%

Valuation

See full

Market cap$910.66M+135%

Enterprise value$634.23M+223%

P/S112.5×-10.3×

Profitability

See full

Operating margin-1,315.2%-4,060pp

Net margin-1,062.3%-251,151pp

FCF margin-1,247.7%-9,569pp

Returns & leverage

See full

Return on equity-57.4%+2.2pp

Debt / equity0.1×0.0×

Current ratio13.1×+2.2×

Where this comes from

Calculated from Solid Biosciences Inc.’s reported figures.

total debt/total assets=0×

Based on the most recent quarter.

The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solid Biosciences Inc.'s debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Solid Biosciences Inc.'s debt-to-assets?: Solid Biosciences Inc. (SLDB) reported debt-to-assets of 0× in Q1 2026.
How has Solid Biosciences Inc.'s debt-to-assets changed year-over-year?: Solid Biosciences Inc.'s debt-to-assets decreased by 28.8% year-over-year, from 0.1× to 0×.
What is the long-term trend for Solid Biosciences Inc.'s debt-to-assets?: Over 5 years (2020 to 2025), Solid Biosciences Inc.'s debt-to-assets has grown at a 23.8% compound annual growth rate (CAGR), from 0× to 0.1×.
What does debt-to-assets mean?: Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.